Quantitative Assessment of Air Trapping in Chronic Obstructive Pulmonary Disease Using Inspiratory and Expiratory Volumetric MDCT

Size: px
Start display at page:

Download "Quantitative Assessment of Air Trapping in Chronic Obstructive Pulmonary Disease Using Inspiratory and Expiratory Volumetric MDCT"

Transcription

1 Chest Imaging Original Research Matsuoka et al. MDCT of Air Trapping in COPD Chest Imaging Original Research Shin Matsuoka 12 Yasuyuki Kurihara 1 Kunihiro Yagihashi 1 Makoto Hoshino 3 Naoto Watanabe 3 Yasuo Nakajima 1 Matsuoka S Kurihara Y Yagihashi K Hoshino M Watanabe N Nakajima Y Keywords: air trapping chronic obstructive pulmonary disease CT emphysema lung DOI: /AJR Received July ; accepted after revision October Department of Radiology St. Marianna University School of Medicine Sugao Miyamae-Ku Kawasaki City Kanagawa Japan. 2 Present address: Department of Radiology Brigham and Women s Hospital Harvard Medical School 75 Francis St. Boston MA Address correspondence to S. Matsuoka (shin4114@mac.com). 3 Division of Respiratory and Infectious Diseases Department of Internal Medicine St. Marianna University School of Medicine Kanagawa Japan. AJR 2008; 190: X/08/ American Roentgen Ray Society Quantitative Assessment of Air Trapping in Chronic Obstructive Pulmonary Disease Using Inspiratory and Expiratory Volumetric MDCT OBJECTIVE. The purpose of our study was to determine the attenuation threshold value for the detection and quantification of air trapping using paired inspiratory and expiratory volumetric MDCT scans and to assess whether the densitometric parameter can be used for the quantification of airway dysfunction in chronic obstructive pulmonary disease (COPD) regardless of the degree of emphysema. materials AND METHODS. This study included 36 patients with COPD who underwent 64-MDCT. The entire lung volume with attenuation between 500 and 1024 H was segmented as whole lung. The lung volume with attenuation between 500 and 950 H was segmented as limited lung while the lung volume of less than 950 H was segmented as emphysema and eliminated. The relative volumes for limited lung (relative volume n 950 ) with attenuation values below thresholds ( n ) ranging from 850 to 950 H and relative volume for whole lung (relative volume <n ) were obtained on inspiratory and expiratory CT. Then the differences of relative volumes after expiration in whole lung (relative volume change <n ) and limited lung (relative volume change n 950 ) were calculated. Patients were classified into two groups according to mean relative volume less than 950 H. Correlations between densitometry parameters and pulmonary function tests (PFTs) reflecting airway dysfunction were evaluated. RESULTS. The highest correlation with PFTs was observed at the upper threshold of 860 H. In the moderate to severe emphysema group (relative volume < 950 > 15%) relative volume significantly correlated with the results of PFTs whereas no significant correlations were seen between relative volume change < 860 and PFTs. In the minimal or mild emphysema group (inspiratory relative volume < 950 < 15%) all densitometric parameters correlated with PFTs. CONCLUSION. The densitometric parameter of relative volume change calculated on paired inspiratory and expiratory MDCT using the threshold of 860 H in limited lung correlated closely with airway dysfunction in COPD regardless of the degree of emphysema. C hronic obstructive pulmonary disease (COPD) is characterized by the presence of airflow limitation [1] caused by small airways disease [2 3] an increase in lung compliance due to emphysematous lung destruction [4] or both. Many studies have assessed the use of CT in the quantitative analysis of those structural abnormalities in COPD. Quantification of the extent and severity of pulmonary emphysema using CT has been reported in numerous studies [5 7]. Meanwhile quantification of small airways disease using CT is less well developed than that of emphysema because recent CT techniques have not yet allowed direct morphologic assessment of small airways. However some studies have shown that the densitomet- ric parameters of lung calculated on paired inspiratory and expiratory CT scans allowed indirect evaluation of airway obstruction in several obstructive lung diseases [8 12]. These quantitative methods are based on the detection of air trapping. Air trapping reflects the retention of excess gas in all or part of the lung and is detected as decreased attenuation on expiratory CT as compared with the corresponding inspiratory images. However in the case of COPD the area of decreased attenuation includes not only air trapping but also emphysema. Thus this method would be influenced by the extent of emphysema. Recently Matsuoka et al. [13] investigated the percentage change of relative area with attenuation values from 900 to 950 H between inspiratory and expiratory CT scans in 762 AJR:190 March 2008

2 MDCT of Air Trapping in COPD patients with COPD. The lower threshold of 950 H was adopted to eliminate the influence of emphysema and the upper threshold value of 900 H was adopted because the relative area in lung less than 900 H on expiratory CT scans correlated to the degree of air trapping [8]. They found that the change in relative area with attenuation values from 900 to 950 H after expiration decreased with the deterioration of the pulmonary function tests (PFTs) reflecting airway obstruction and that change correlated more closely with airway obstruction than change of relative area with attenuation values less than 900 H including emphysema. Those authors concluded that their method using paired inspiratory and expiratory CT could be useful for the quantitative evaluation of air trapping in COPD without the influence of emphysema. Unfortunately their study had several limitations: First the validity of using a threshold of 900 H for the evaluation of air trapping was not confirmed. In fact the appropriate attenuation threshold value for the quantification of air trapping on paired inspiratory and expiratory CT has not been clarified. Second they obtained densitometric parameters from only six slices using a 2D analysis. Thus the misregistration of CT slices between inspiration and expiration might have influenced their results. In addition both emphysema and air trapping are heterogeneously distributed throughout the lung in COPD. Only six slices would not reflect morphologic and functional abnormalities in the whole lung. Those authors should have assessed whole-lung volumetric data. Third most of their subjects had severe emphysema. The adaptability of this method to the patient without severe emphysema was not confirmed. Thus the validity of this method is expected to improve by solving these limitations. The first aim of our study was to determine the attenuation threshold value for the detection and quantification of air trapping using paired inspiratory and expiratory volumetric MDCT scans. The second aim of this study was to assess whether the densitometric parameter can be used for the quantification of airway dysfunction in COPD without being influenced by the degree of emphysema. Materials and Methods Subjects This retrospective study was approved by our institutional review board which waived the need for informed consent. One radiologist with 15 years of experience in chest CT reviewed medical records and MDCT images obtained between October 2005 and September 2006 in our institution and 45 consecutive patients with COPD who underwent PFTs within 2 weeks of undergoing MDCT were selected. The clinical indications for these scans were variable including detection or routine observation of emphysema. COPD subjects from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) [14] stages I IV were included. Exclusion criteria were prior cardiopulmonary disease obvious abnormal lung parenchymal lesions except for emphysema pleural effusion nondiagnostic CT image due to breathing motion artifact and contrastenhanced CT study. Nine patients were excluded from further analysis for the following reasons: prior cardiopulmonary disease (n = 2) obvious abnormal parenchymal lesions except for emphysema (n = 4) pleural effusion (n = 1) nondiagnostic CT image due to breathing motion artifacts (n = 1) and contrastenhanced CT study (n = 1). Thus 36 patients (31 men and five women; mean age 71 years; range years) were included in this study. All patients had a history of smoking. Patient characteristics are summarized in Table 1. MDCT All patients were scanned with a 64-MDCT scanner (Aquilion-64 Toshiba Medical Systems). The scanner was calibrated regularly with air and a water phantom to allow reliable measurements. CT was performed during deep inspiratory and expiratory breath-holding with the patient in the supine position. Every patient was carefully instructed how to breathe before the study and again right before the scanning. MDCT parameters for both scans were as follows: collimation 0.5 mm; 120 kv; 200 ma; gantry rotation time 0.5 second; beam pitch 53/64. All images were reconstructed using a standard reconstruction algorithm with a slice thickness of 1 mm and a reconstruction interval of 0.5 mm. Quantitative Assessment of Lung Attenuation The reconstruction images were transferred to a workstation (Ziostation Ziosoft). This workstation uses a semiautomatic threshold technique to isolate lung volume from other tissues and structures using CT attenuation values of 500 to 1024 H; the volume of the entire lung was calculated by summing the voxels in those attenuation values and was defined as the whole lung. Minimal user intervention by one radiologist was required to exclude nonlung structures that satisfied the threshold criteria such as the trachea and large bronchi near the hilum. Then the lung volumes with attenuation values lower than thresholds ranging from 850 to 950 H ( and 950 H) were obtained on both inspiratory and expiratory scans. The percentage of the lung volume with attenuation values lower than each threshold value for the whole lung were calculated as relative volume of the whole lung on both inspiratory and expiratory scans (relative volume <n [%] = volume with attenuation values less than each threshold / volume with attenuation value of 500 to 1024 H; for inspir atory TABLE 1: Patient Characteristics and Results of Pulmonary Function Texts in 36 Patients Characteristic Mean ± SD Median Range Age (y) 71.0 ± Pack-years (no.) 34.5 ± Height (cm) ± Weight (kg) 54.4 ± FVC (% predicted) 94.6 ± (% predicted) 67.8 ± /FVC 51.7 ± (% predicted) 27.2 ± FRC (% predicted) ± TLC (% predicted) ± RV (% predicted) ± RV/TLC 47.0 ± (% predicted) 44.3 ± Note FVC = forced vital capacity = forced expiratory volume in 1 second = mid expiratory phase of forced expiratory flow FRC = functional residual capacity RV = residual volume TLC = total lung capacity RV/TLC = ratio of residual volume to total lung capacity DLco = diffusing capacity of lung for carbon monoxide. AJR:190 March

3 Matsuoka et al. relative volume <n and expiratory relative volume <n n = each selected attenuation threshold value between 850 and 950 H) (Fig. 1). Next the lung volume with attenuation values between 500 and 950 H was segmented as the limited lung (Fig. 1) which was considered eliminating emphysematous lesions from the whole lung. The lowest threshold of 950 H was chosen because this threshold has been validated macroscopically and microscopically for thinsection CT studies of the extent of emphysema [5 6]. Then the percentage of lung volume with attenuation values between 950 H and each threshold value ranging from 850 to 930 H for A the limited lung were calculated as relative volume of the limited lung on both inspiratory and expiratory scans (relative volume n 950 = lung volume with attenuation values between 950 H and each threshold value / volume with attenuation value of 500 to 950 H; for inspiratory relative volume n 950 and expiratory relative volume n 950 n = each selected attenuation threshold value between 850 and 930 H) (Fig. 1). To evaluate the change of relative volume after expiration the difference between the relative volumes on expiratory CT and inspiratory CT in the whole lung (relative volume change <n ) and the limited lung (relative volume change n 950 ) were calculated using the following formulas: relative volume change <n = expiratory relative volume <n inspiratory relative volume <n ; relative volume change n 950 = expiratory relative volume n 950 inspiratory relative volume n 950 ; n = each selected attenuation threshold value between 850 and 930 H. Pulmonary Function Tests PFTs were performed within 2 weeks of obtaining thin-section CT scans. PFTs including spirometry and measurement of diffusing capacity for carbon monoxide ( ) were performed. Forced expiratory volume in 1 second ( ) and forced vital capacity (FVC) were measured according to standard D E F Fig year-old man with chronic obstructive pulmonary disease. Three-dimensional images anterior view reconstructed from inspiratory and expiratory MDCT. A Segmented whole-lung volume with voxels of attenuation values between 500 and 1024 H on inspiratory CT (blue). B Segmented lung volume with attenuation values less than 860 H in inspiratory CT (red). C Segmented lung volume with attenuation values less than 860 H in expiratory CT (red). Relative volumes for whole lung with attenuation value less than 860 H are calculated as follows: relative volume on inspiratory CT (inspiratory relative volume < 860 ) = (red in B) / (blue in A) and relative volume on expiratory CT (expiratory relative volume < 860 ) = (red in C) / segmented whole-lung volume on expiratory CT. Relative volume change < 860 = expiratory relative volume < 860 inspiratory relative volume < 860. D Segmented limited-lung volume with voxels having attenuation values between 500 and 950 H on inspiratory CT (yellow). E Segmented lung volume with attenuation values between 860 and 950 H at upper threshold of 860 H on inspiratory CT (green). F Segmented lung volume with attenuation values between 860 and 950 H at upper threshold of 860 H on expiratory CT (green). Relative volume for limited lung is obtained as follows: relative volume on inspiratory CT (inspiratory relative volume ) = (green in E) / (yellow in D) and relative volume on expiratory CT (expiratory relative volume ) = (green in F) / segmented limited-lung volume on expiratory CT. Relative volume = expiratory relative volume inspiratory relative volume B C 764 AJR:190 March 2008

4 MDCT of Air Trapping in COPD TABLE 2: Correlation Between Measured Relative Volume Change in Limited Lung and Results of Pulmonary Function Tests Upper Threshold (H) Relative Volume Change (%P) /FVC (%P) RV/TLC FVC (%P) DLco (%P) Mean ± SD Median r p r p r p r p r p r p ± ± ± ± ± < < < < < ± < < < < < < ± < < < < < < ± < < < < < < ± < < < < < < Note Relative volume change is difference in relative volume of limited lung between inspiratory and expiratory CT. %P = % predicted. FVC = forced vital capacity = forced expiratory volume in 1 second = mid expiratory phase of forced expiratory flow FRC = functional residual capacity RV = residual volume TLC = total lung capacity RV/TLC = ratio of residual volume to total lung capacity DLco = diffusing capacity of the lung for carbon monoxide. techniques and the ratio of to the forced vital capacity ( /FVC) and mid expiratory phase of the forced expiratory flow ( ) were obtained. The lung volume subdivisions of functional residual capacity (FRC) residual volume (RV) and total lung capacity (TLC) were measured with the helium dilution method. Values for each PFT except for RV/TLC and /FVC were expressed as percentages of predicted values according to the prediction equations described previously [15]. was measured by the singlebreath method and the predicted values for were determined as described previously [15]. Statistical Analysis To obtain the attenuation threshold value for the detection and quantification of air trapping we calculated Spearman s correlation coefficients between each relative volume change n 950 and the results of PFTs ( /FVC and RV/TLC). Next all patients were classified into two groups according to the extent of emphysema obtained on the basis of the mean value of inspiratory relative volume < 950. Using that threshold value (n*) obtained from this study Spearman s correlation coefficients between the expiratory relative volume <n* expiratory relative volume n* 950 relative volume change <n* or relative volume change n* 950 and the results of PFTs ( /FVC FVC RV/TLC and ) in both groups were obtained. Comparisons of expiratory relative volume <n* expiratory relative volume n* 950 relative volume change <n* or relative volume change n* 950 between the moderate to severe emphysema group and the minimal or mild emphysema group were done using the Wilcoxon s signed rank test. All statistical analyses were performed using JMP software (SAS Institute). Data are expressed as mean ± SD. For all statistical analyses a p value of less than 0.05 was considered significant. Results Threshold Value of Relative Volume Change n 950 The correlations between the measured relative volume change n 950 values and the results of PFTs are shown in Table 2. Relative volume change n 950 with threshold values from 850 to 880 H had significant correlations with the results of /FVC and RV/TLC. Depending on the results of correlations with and RV/TLC the highest correlation was observed at the upper threshold value of 860 H (r = 0.75 p < for ; and r = 0.70 p < for RV/ TLC respectively). Thus we chose the upper threshold value of 860 H for the subsequent evaluation. The relationships between relative volume and or RV/ TLC are illustrated in Figure 2. Densitometric Parameters in Whole and Limited Lung Mean value of the inspiratory relative volume < 950 was 15.1% ± 14.3%. According to the mean value of the inspiratory relative volume < 950 all patients were divided into two groups as follows: moderate to severe emphysema group (inspiratory relative volume < 950 > 15%): 14 patients (13 men and one woman; mean age 72.1 years; mean inspiratory relative volume < % ± 12.3%) minimal or mild emphysema group (inspiratory relative volume < 950 < 15%): 22 patients (18 men and four women; mean age 70.4 years; mean inspiratory relative volume < % ± 4.6%). The results of densitometric parameters are shown in Table 3. Significant differences were seen in expiratory relative volume < 860 expiratory relative volume relative volume change < 860 or relative volume between the moderate to severe emphysema group and the minimal or mild emphysema group (p < respectively). In the moderate to severe emphysema group relative volume significantly correlated with results of PFTs that associate with airway dysfunction (r = 0.76 p = for ; r = 0.64 p = for /FVC; r = 0.61 p = 0.02 for ; and r = 0.79 p < for RV/TLC). No significant correlations were seen between relative volume change < 860 expiratory relative volume or expiratory relative volume < 860 and results of PFTs. In the minimal or mild emphysema group relative volume significantly correlated with results of PFTs that associate with airway dysfunction (r = 0.56 p = for ; r = 0.56 p = for / FVC; r = 0.55 p = for ; and r = 0.50 p = for RV/TLC). The correlation coefficients between relative volume change < 860 and the results of PFTs were the same as the correlation between relative volume and the results of PFTs that associate with airway dysfunction. No significant correlations were seen between relative volume relative volume change < 860 expiratory relative volume or the expiratory relative volume < 860 and the in the minimal or mild emphysema AJR:190 March

5 Matsuoka et al FEF 25 75% (% predicted) Relative Volume Change group. The correlation between the densitometric parameters and the results of PFTs are shown in Table 4. Discussion In our study we found that the change of relative volume of limited lung with attenuation values between 860 and 950 H after expiration had the best correlation with results of PFTs that associate with airway dysfunction. In the moderate to severe emphysema group relative volume was the only parameter that could reflect airway dysfunction. Moreover even in the minimal or mild emphysema group relative volume correlated with the results of PFTs reflecting airway dysfunction. Consequently the parameter of relative volume A B Fig. 2 Relationships with relative volume change. Excellent correlation is observed at upper threshold value of 860 H with pulmonary function tests that reflect peripheral airway obstruction and air trapping. A and B Graphs show relationships between relative volume and forced expiratory flow (FEF) 25 75% (r = 0.75 p < 0.001) (A) and between relative volume and ratio of residual volume to total lung capacity (RV/TLC) (r = 0.70 p < 0.001) (B). TABLE 3: Results of Densitometry Parameters Patient Group Relative Volume Change a RV/TLC can be used for the quantification of airway dysfunction in patients with COPD regardless of the degree of emphysema. Although emphysema is now detectable with the use of CT it is difficult to quantify airway obstruction and air trapping in patients with COPD. However several researchers have tried to quantify the degree of air trapping using densitometric techniques on expiratory or paired inspiratory and expiratory CT in various obstructive lung diseases [8 12]. It has been reported that the area of air trapping does not show an increase in CT attenuation and remains more radiolucent than the surrounding normal pulmonary tissue [16 18]. Consequently the degree of the change of the lung attenuation value after expiration has been quantified using some densitometric parameters such as Relative Volume Change < 860 b Relative Volume Change Expiratory Relative Volume c the relative area below a certain threshold value or the ratio of mean lung attenuation value of inspiration and expiration. However these densitometric parameters were calculated from lung attenuation including values less than 950 H that reflect the extent of emphysema. Moreover the relative area with attenuation values less than 950 H is not appreciably changed after expiration as compared with the relative area of decreased attenuation with values more than 950 H [ ]. Therefore the exclusion of the pixels less than 950 H on both inspiratory and expiratory CT is desirable for the quantification of air trapping without influence of the extent of emphysema. Actually in the moderate to severe emphysema group relative volume was the only parameter that 0 Expiratory Relative Volume < 860 d Mean ± SD Median Mean ± SD Median Mean ± SD Median Mean ± SD Median All patients (n = 36) 22.7 ± ± ± ± Moderate to severe emphysema group (n = 14) Minimal or mild emphysema group (n = 22) 10.2 ± ± ± ± ± ± ± ± a Difference in relative volume of limited lung between inspiratory and expiratory CT. b Difference in relative volume of whole lung between inspiratory and expiratory CT. c Percentage of lung volume with attenuation values between 860 and 950 H for limited lung. d Percentage of lung volume with attenuation values < 860 H for whole lung AJR:190 March 2008

6 MDCT of Air Trapping in COPD TABLE 4: Correlation Between Densitometry Parameters and Results of Pulmonary Function Tests Pulmonary Function Test All patients (n = 36) Relative Volume Change a related to the result of PFTs associated with airway obstruction and air trapping. Meanwhile no significant correlations were seen between the results of PFTs reflecting airway dysfunction and relative volume change < 860 which is the parameter including voxels with attenuation values less than 950 H regarding the extent of emphysema. In addition no significant correlations were found between airway dysfunction and the densitometric parameters obtained on only expiratory CT such as expiratory relative volume < 860 or expiratory relative volume in the emphysema-dominant group. These results could support the necessity of using paired inspiratory and expiratory CT for the quantification of airway dysfunction in COPD with emphysema. Although the value of 950 H is recognized as an acceptable cutoff for segmentation of emphysema emphysema also exists Relative Volume Change < 860 b in areas having lung attenuation greater than 950 H [20]. Furthermore Gevenois et al. [21] showed that the threshold of 910 H on expiratory CT scans correlated better with the macroscopic assessment of emphysema. Therefore the emphysematous lesions cannot be completely excluded using the cutoff value of 950 H and they contribute to airway dysfunction to some degree. However in our study and in a previous study [13] densitometric parameters with attenuation less than 950 H are not strongly related to airway dysfunction. Therefore although airflow limitation in COPD is a dynamic phenomenon related to both small airways disease [1 3] and an increase in lung compliance due to emphysematous lung destruction [4] our results suggest that the extent of emphysema is not the major cause of airflow limitation in COPD. Expiratory Relative Volume c Expiratory Relative Volume < 860 d r p r p r p r p (%P) 0.80 < e 0.77 < e 0.75 < e 0.78 < e /FVC 0.78 < e 0.75 < e 0.76 < e 0.77 < e (%P) 0.75 < e 0.71 < e 0.73 < e 0.74 < e RV/TLC 0.70 < e 0.63 < e 0.62 < e 0.60 < e FVC (%P) 0.60 < e 0.63 < e 0.53 < e 0.59 < e (%P) 0.56 < e 0.61 < e 0.58 < e 0.64 < e Moderate to severe emphysema group (n = 14) (%P) e /FVC e (%P) e RV/TLC 0.79 < e FVC (%P) e (%P) Minimal or mild emphysema group (n = 22) (%P) e e e e /FVC e e 0.67 < e 0.68 < e (%P) e e e 0.66 < e RV/TLC e e e e FVC (%P) e e (%P) e e e e Note %P = % predicted. a Difference in relative volume of limited lung between inspiratory and expiratory CT. b Difference in relative volume of whole lung between inspiratory and expiratory CT. c Percentage of lung volume with attenuation values between 860 and 950 H for limited lung. d Percentage of lung volume with attenuation values < 860 H for whole lung. e p < 0.05 Spearman s correlation analysis. The threshold value that regulates the extent and degree of air trapping also has not sufficiently been clarified. In our study the upper attenuation threshold value of 860 H had the highest correlation with results of and RV/TLC which indicate airway obstruction and air trapping. However we cannot explain why the attenuation value of 860 H is the best threshold to quantify the extent of air trapping. Using lung volume data from all subjects in our study the frequency distribution of pixels in the lung on both inspiration and expiration shows that the percentages of pixels at the attenuation value of 860 H on both inspiration and expiration are equivalent and at more than 860 H the percentage of pixels on expiratory CT is greater than that on inspiratory CT (Fig. 3). Thus differences in relative volume between inspiration and expiration AJR:190 March

7 Matsuoka et al. Pixels Lung Attenuation Value (H) could be detected effectively at the attenuation value of less than 860 H. Future evaluation of the relationship between the change in relative volume after expiration and the physiologic bases is required. Meanwhile in our study although the upper attenuation threshold value of 860 H had the highest correlation with results of PFTs most correlations with the results of PFTs are similar to each other especially between 850 and 880 H. Actually in both the moderate to severe emphysema group and the minimal or mild emphysema group the correlation between the densitometry parameters with attenuation values of and 880 H were not quite different from the result of using a threshold value of 860 H (data not shown). Therefore the optimal threshold could vary between 850 and 880 H because of variable conditions such as calibration of the CT scanner. In this study no significant correlation was seen between all densitometric parameters and in the moderate to severe emphysema group. In contrast the reduction of correlated with the increased values of all densitometric parameters in the minimal or mild emphysema group. The decrease of is probably the result of loss of alveolar surface area such as occurs in emphysema [22 23]. However alone is not specific for the diagnosis of emphysema [24]. Many studies have also found that measurement of has a weak correlation with the pathologic assessment of emphysema [25]. At the same time airflow obstruction especially that induced by airway dysfunction may enhance Fig. 3 Frequency distribution of pixels in lung on inspiratory ( ) and expiratory ( ) CT in this study. Percentages of pixels at attenuation of 860 H on both inspiratory and expiratory CT are equivalent; at more than 860 H percentage of pixels on expiratory CT is greater than on inspiratory CT. functional inhomogeneities and impairs [26]. In the minimal or mild emphysema group reduction of might correlate with functional inhomogeneities due to airway obstruction. Hence it could be reasonable to find correlations between relative volume change which reflects air dysfunction and the reduction of in the minimal or mild emphysema group. Several studies have addressed the ability of 3D volumetric data to accurately quantify the extent and severity of emphysema [27 29]. In previous studies comparing only a few single inspiratory and expiratory image pairs the misregistrations of CT slices between inspiration and expiration might be due to disturbances of accurate evaluation of airway dysfunction. Because MDCT has the major advantage that the entire thorax is imaged during a single breath-hold the disadvantage of using single-detector CT has been overcome. Meanwhile expiratory CT does expose patients to additional radiation and multidetector technology can further increase the delivered dose. Therefore further research is needed to optimize radiation dose for the quantification of airway dysfunction. In the past few years much attention has been paid to therapeutic agents that specifically address airflow obstruction in patients with COPD [30 32]. Although emphysematous lesions are irreversible there is a good chance for treatment and prevention of airway obstruction in patients with COPD. Quantitative CT analysis has been used to assess the relative efficacy of drugs on small airway hyperreactivity and regional air trapping [30]. The evaluation of drug efficacy in the peripheral airways is important and progress toward specific treatment for COPD might be accelerated by moving beyond the measurement of airflow limitation to the precise diagnosis of the specific targets responsible for the airflow limitation. The efficacy of various drugs might be best assessed using the paired inspiratory and expiratory CT analysis in the limited lung especially in COPD patients because this method allows a more accurate assessment of peripheral airway obstruction without the influence of the extent of emphysema. Our study has several limitations. First the number of patients was relatively small. To prove the validity of our method for the quantification of air trapping this method should be applied to a prospective larger set of patients with various degrees of emphysema. Second the concept and definition of air trapping are still confusing and not agreed upon. On CT images it is generally accepted that the area of air trapping does not show a significant increase in CT attenuation. According to this concept to quantify air trapping we must match each lung area on inspiratory and expiratory CT and compare the CT density between inspiratory and expiratory scans. However we did not perform pixel-by-pixel comparison. Thus some areas having a value less than 950 H on inspiration CT may have the value of 860 to 950 H on expiration CT which may affect the results to some degree. Moreover we decided on the optimal upper threshold value of 860 H depending on correlations with the results of and RV/TLC. However in the strict sense and RV/TLC are not entirely representative of small airway obstruction and air trapping. Therefore relative volume might reflect not only a limitation in airflow caused by small airways disease but also other pathophysiologic conditions. Third CT densitometry is influenced by the level of inspiration during CT [33]. A spirometrically controlled CT technique has been developed offering the opportunity to obtain CT scans at defined levels of inspiration [34 35]. In conclusion using paired inspiratory and expiratory MDCT the change in relative lung volume with attenuation values from 860 to 950 H after expiration correlated closely with results of PFTs reflecting the severity of airway dysfunction. Furthermore the result of the correlations of densitometry parameters and PFTs indicated that the relative volume 768 AJR:190 March 2008

8 MDCT of Air Trapping in COPD was the only parameter that could reflect airway dysfunction in both the moderate to severe emphysema group and the minimal or mild emphysema group. Thus the densitometry parameter of relative volume can be used for the quantification of air trapping in patients with COPD regardless of the degree of emphysema. References 1. Pauwels RA Buist AS Calverley PM Jenkins CR Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: Hogg JC Macklem PT Thurlbeck WM. Site and nature of airways obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278: Yanai M Sekizawa K Ohrui T Sasaki H Takishima T. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992; 72: Mead J Turner JM Macklem PT Little J. Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol 1967; 22: Gevenois PA de Maertelaer V De Vuyst P Zanen J Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152: Gevenois PA De Vuyst P de Maertelaer V et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996; 154: Madani A Zanen J de Maertelaer V Gevenois PA. Pulmonary emphysema: objective quantification at multi-detector row CT comparison with macroscopic and microscopic morphometry. Radiology 2006; 238: Newman KB Lynch DA Newman LS Ellegood D Newell JD Jr. Quantitative computed tomography detects air trapping due to asthma. Chest 1994; 106: Lamers RJ Thelissen GR Kessels AG Wouters EF van Engelshoven JM. Chronic obstructive pulmonary disease: evaluation with spirometrically controlled CT lung densitometry. Radiology 1994; 193: Eda S Kubo K Fujimoto K Matsuzawa Y Sekiguchi M Sakai F. The relations between expiratory chest CT using helical CT and pulmonary function tests in emphysema. Am J Respir Crit Care Med 1997; 155: Kubo K Eda S Yamamoto H et al. Expiratory and inspiratory chest computed tomography and pulmonary function tests in cigarette smokers. Eur Respir J 1999; 13: O Donnell RA Peebles C Ward JA et al. Relationship between peripheral airway dysfunction airway obstruction and neutrophilic inflammation in COPD. Thorax 2004; 59: Matsuoka S Kurihara Y Yagihashi K Nakajima Y. Quantitative assessment of peripheral airway obstruction on paired expiratory/inspiratory thinsection CT in COPD with emphysema. J Comput Assist Tomogr 2007; 31: Global Initiative for Chronic Lung Disease. Global strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease updated NHLBI/WHO workshop and report. Bethesda MD: National Heart Lung and Blood Institute. Available at GOLD Website (www. goldcopd.org/). Accessed November The Committee of Pulmonary Physiology Japanese Respiratory Society. Guidelines for pulmonary function tests. spirometry flow-volume curve diffusion capacity of the lung. Tokyo Japan: The Japanese Respiratory Society 2004 (in Japanese) 16. Webb WR Stern EJ Kanth N Gamsu G. Dynamic pulmonary CT: findings in healthy adult men. Radiology 1993; 186: Stern EJ Webb WR. Dynamic imaging of lung morphology with ultrafast high-resolution CT. J Thorac Imaging 1993; 8: Stern EJ Frank MS. Small-airway disease of the lungs: findings at expiratory CT. AJR 1994; 163: Kauczor HU Hast J Heussel CP Schlegel J Mildenberger P Thelen M. CT attenuation of paired HRCT scans obtained at full inspiratory/ expiratory position: comparison with pulmonary function tests. Eur Radiol 2002; 12: Coxson HO Rogers RM Hogg JC et al. A quantification of the lung surface area in emphysema using computed tomography. Am J Respir Crit Care Med 1999; 159: Gevenois PA De Vuyst P Sy M et al. Pulmonary emphysema: quantitative CT during expiration. Radiology 1996; 199: Gould GA MacNee W McLean A et al. CT measurements of lung density in life can quantitate distal airspace enlargement: an essential defining feature of human emphysema. Am Rev Respir Dis 1988; 137: McLean A Warren PM Gillooly M MacNee W Lamb D. Microscopic and macroscopic measurements of emphysema: relation to carbon monoxide gas transfer. Thorax 1992; 47: MacNee W Gould G Lamb D. Quantifying emphysema by CT scanning: clinicopathologic correlates. Ann N Y Acad Sci 1991; 624: West WW Nagai A Hodgkin JE Thurlbeck WM. The National Institutes of Health Intermittent Positive Pressure Breathing trial: pathology studies. III. The diagnosis of emphysema. Am Rev Respir Dis 1987; 135: Yamaguchi K Mori M Kawai A Takasugi T Oyamada Y Koda E. Inhomogeneities of ventilation and the diffusing capacity to perfusion in various chronic lung diseases. Am J Respir Crit Care Med 1997; 156: Mergo PJ Williams WF Gonzalez-Rothi R et al. Three-dimensional volumetric assessment of abnormally low attenuation of the lung from routine helical CT: inspiratory and expiratory quantification. AJR 1998; 170: Park KJ Bergin CJ Clausen JL. Quantitation of emphysema with three-dimensional CT densitometry: comparison with two-dimensional analysis visual emphysema scores and pulmonary function test results. Radiology 1999; 211: Zaporozhan J Ley S Eberhardt R et al. Paired inspiratory/expiratory volumetric thin-slice CT scan for emphysema analysis: comparison of different quantitative evaluations and pulmonary function test. Chest 2005; 128: Goldin JG Tashkin DP Kleerup EC et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 1999; 104:S258 S Sin DD McAlister FA Man SF Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003; 290: Burge PS Calverley PM Jones PW. Randomized double blind placebo controlled trial of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: Wegener OH Koeppe P Oeser H. Measurement of lung density by computed tomography. J Comput Assist Tomogr 1978; 2: Kohz P Stabler A Beinert T et al. Reproducibility of quantitative spirometrically controlled CT. Radiology 1995; 197: Kalender WA Rienmuller R Seissler W Behr J Welke M Fichte H. Measurement of pulmonary parenchymal attenuation: use of spirometric gating with quantitative CT. Radiology 1990; 175: AJR:190 March

Quantitative CT in Chronic Obstructive Pulmonary Disease: Inspiratory and Expiratory Assessment

Quantitative CT in Chronic Obstructive Pulmonary Disease: Inspiratory and Expiratory Assessment Cardiopulmonary Imaging Original Research kira et al. CT of Chronic Obstructive Pulmonary Disease Cardiopulmonary Imaging Original Research Masanori kira 1 Kazushige Toyokawa 1 Yoshikazu Inoue 2 Toru rai

More information

Sang Min Lee, M.D., Jin Hur, M.D., Tae Hoon Kim, M.D., Sang Jin Kim, M.D., Hyung Jung Kim, M.D. 2

Sang Min Lee, M.D., Jin Hur, M.D., Tae Hoon Kim, M.D., Sang Jin Kim, M.D., Hyung Jung Kim, M.D. 2 Quantitative Assessment of Lung Volumes using Multidetector Row Computed Tomography (MDCT) in Patients with Chronic Obstructive Pulmonary Disease (COPD) 1 Sang Min Lee, M.D., Jin Hur, M.D., Tae Hoon Kim,

More information

Chapter 11. Summary and general discussion

Chapter 11. Summary and general discussion Chapter 11 Summary and general discussion Low Dose Computed Tomography of the Chest: Applications and Limitations INTRODUCTION The introduction of spiral, multidetector-row computed tomography (CT) has

More information

Copyright 2008 Society of Photo Optical Instrumentation Engineers. This paper was published in Proceedings of SPIE, vol. 6915, Medical Imaging 2008:

Copyright 2008 Society of Photo Optical Instrumentation Engineers. This paper was published in Proceedings of SPIE, vol. 6915, Medical Imaging 2008: Copyright 2008 Society of Photo Optical Instrumentation Engineers. This paper was published in Proceedings of SPIE, vol. 6915, Medical Imaging 2008: Computer Aided Diagnosis and is made available as an

More information

HRCT Versus Volume Rendering (Three Colors, Three Densities Lung Images) in Diagnosis of Small Airway Disease: A Comparative Study

HRCT Versus Volume Rendering (Three Colors, Three Densities Lung Images) in Diagnosis of Small Airway Disease: A Comparative Study Med. J. Cairo Univ., Vol. 84, No. 1, March: 359-364, 2016 www.medicaljournalofcairouniversity.net HRCT Versus Volume Rendering (Three Colors, Three Densities Lung Images) in Diagnosis of Small Airway Disease:

More information

CT-Densitometry A structure-based quantitative analysis of lung-ct in emphysema

CT-Densitometry A structure-based quantitative analysis of lung-ct in emphysema CT-Densitometry A structure-based quantitative analysis of lung-ct in emphysema R.A. Blechschmidt and U. Lörcher Department of Radiology, Deutsche Klinik für Diagnostik Aukammallee 33, 65191 Wiesbaden,

More information

C hronic obstructive pulmonary disease (COPD) develops

C hronic obstructive pulmonary disease (COPD) develops 837 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD R A O Donnell, C Peebles, J A Ward, A Daraker, G

More information

Normal Range of Emphysema and Air Trapping on CT in Young Men

Normal Range of Emphysema and Air Trapping on CT in Young Men Cardiopulmonary Imaging Original Research Mets et al. CT of Emphysema and Air Trapping Cardiopulmonary Imaging Original Research Onno M. Mets 1 Robert A. van Hulst 2,3 Colin Jacobs 4,5 Bram van Ginneken

More information

Key words: bronchodilation; diffusing capacity; high-resolution CT; lung volumes; spirometry

Key words: bronchodilation; diffusing capacity; high-resolution CT; lung volumes; spirometry Assessment of Emphysema in COPD* A Functional and Radiologic Study Isa Cerveri, MD; Roberto Dore, MD; Angelo Corsico, MD, PhD; Maria C. Zoia, MD; Riccardo Pellegrino, MD; Vito Brusasco, MD; and Ernesto

More information

Quantitative evaluation by high resolution computed tomography (HRCT) of patients with asthma and emphysema

Quantitative evaluation by high resolution computed tomography (HRCT) of patients with asthma and emphysema 19 Evaluation by HRCT in asthma and emphysema Quantitative evaluation by high resolution computed tomography (HRCT) of patients with asthma and emphysema Fumihiro Mitsunobu, Takashi Mifune, Kozo Ashida,

More information

Teacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology

Teacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology Title: Spirometry Teacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology I. Measurements of Ventilation Spirometry A. Pulmonary Volumes 1. The tidal

More information

PFT Interpretation and Reference Values

PFT Interpretation and Reference Values PFT Interpretation and Reference Values September 21, 2018 Eric Wong Objectives Understand the components of PFT Interpretation of PFT Clinical Patterns How to choose Reference Values 3 Components Spirometry

More information

Expiratory and inspiratory chest computed tomography and pulmonary function tests in cigarette smokers

Expiratory and inspiratory chest computed tomography and pulmonary function tests in cigarette smokers Eur Respir J 1999; 13: 252±256 Printed in UK ± all rights reserved Copyright ERS Journals Ltd 1999 European Respiratory Journal ISSN 0903-1936 Expiratory and inspiratory chest computed tomography and pulmonary

More information

Computed Tomography-Based Centrilobular Emphysema Subtypes Relate with Pulmonary Function

Computed Tomography-Based Centrilobular Emphysema Subtypes Relate with Pulmonary Function Send Orders of Reprints at reprints@benthamscience.net 54 The Open Respiratory Medicine Journal, 213, 7, 54-59 Computed Tomography-Based Centrilobular Emphysema s Relate with Pulmonary Function Mamoru

More information

What do pulmonary function tests tell you?

What do pulmonary function tests tell you? Pulmonary Function Testing Michael Wert, MD Assistant Professor Clinical Department of Internal Medicine Division of Pulmonary, Critical Care, and Sleep Medicine The Ohio State University Wexner Medical

More information

Three Cuts Method for Identification of COPD

Three Cuts Method for Identification of COPD ORIGINAL REPORT Three Cuts Method for Identification of COPD Mohammad-Parsa Hosseini 1,2, Hamid Soltanian-Zadeh 2,3, and Shahram Akhlaghpoor 4 1 Department of Electrical & Computer Engineering, Wayne State

More information

Parametric response mapping

Parametric response mapping Parametric response mapping Utility of a novel imaging biomarker in pulmonary disease Dharshan Vummidi MD, Lama VN MD, Yanik G MD, Kazerooni EA MD, Meilan Han MD, Galban C PhD Radiology, Pulmonary & Critical

More information

collapse in patients with tracheobronchomalacia,

collapse in patients with tracheobronchomalacia, J. Zhang 1,2 I. Hasegawa 1,3 H. Hatabu 1,3 D. Feller-Kopman 1,3 P. M. Boiselle 1,3 Received June 5, 2003; accepted after revision July 23, 2003. 1 Department of Radiology, Beth Israel Deaconess Medical

More information

Division of Medicine, "Division of Rehabilitation, Misasa Medical Center, Okayama University Medical and Dental School

Division of Medicine, Division of Rehabilitation, Misasa Medical Center, Okayama University Medical and Dental School 35 Low attenation area in asthma and Difference in low attenuation area (LAA) of the lungs on high resolution computed tomography (HRCT) between asthma and in relation to cigarette smoking Fumihiro Mitsunobu,

More information

Pulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?

Pulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test? Pulmonary Function Testing: Concepts and Clinical Applications David M Systrom, MD Potential Conflict Of Interest Nothing to disclose pertinent to this presentation BRIGHAM AND WOMEN S HOSPITAL Harvard

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Regan EA, Lynch DA, Curran-Everett D, et al; Genetic Epidemiology of COPD (COPDGene) Investigators. Clinical and radiologic disease in smokers with normal spirometry. Published

More information

TORCH: Salmeterol and Fluticasone Propionate and Survival in COPD

TORCH: Salmeterol and Fluticasone Propionate and Survival in COPD TORCH: and Propionate and Survival in COPD April 19, 2007 Justin Lee Pharmacy Resident University Health Network Outline Overview of COPD Pathophysiology Pharmacological Treatment Overview of the TORCH

More information

Dependent Lung Opacity at Thin-Section CT: Evaluation by Spirometrically-Gated CT of the Influence of Lung Volume

Dependent Lung Opacity at Thin-Section CT: Evaluation by Spirometrically-Gated CT of the Influence of Lung Volume Dependent Lung Opacity at Thin-Section CT: Evaluation by Spirometrically-Gated CT of the Influence of Lung Volume Ki-Nam Lee, MD 1 Seong Kuk Yoon, MD 1 Choon Hee Sohn, MD 2 Pil Jo Choi, MD 3 W. Richard

More information

Copyright 2009 Society of Photo Optical Instrumentation Engineers. This paper was published in Proceedings of SPIE, vol. 7260, Medical Imaging 2009:

Copyright 2009 Society of Photo Optical Instrumentation Engineers. This paper was published in Proceedings of SPIE, vol. 7260, Medical Imaging 2009: Copyright 2009 Society of Photo Optical Instrumentation Engineers. This paper was published in Proceedings of SPIE, vol. 7260, Medical Imaging 2009: Computer Aided Diagnosis and is made available as an

More information

Pulmonary Function Testing The Basics of Interpretation

Pulmonary Function Testing The Basics of Interpretation Pulmonary Function Testing The Basics of Interpretation Jennifer Hale, M.D. Valley Baptist Family Practice Residency Objectives Identify the components of PFTs Describe the indications Develop a stepwise

More information

Relationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPD

Relationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPD c Additional Methods information is published online only at http://thorax.bmj.com/ content/vol64/issue4 First Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan Correspondence

More information

Michael L. Goris, MD, PhD; Hongyun J. Zhu, MD; Francis Blankenberg, MD; Frandics Chan, MD, PhD; and Terry E. Robinson, MD

Michael L. Goris, MD, PhD; Hongyun J. Zhu, MD; Francis Blankenberg, MD; Frandics Chan, MD, PhD; and Terry E. Robinson, MD An Automated Approach to Quantitative Air Trapping Measurements in Mild Cystic Fibrosis* Michael L. Goris, MD, PhD; Hongyun J. Zhu, MD; Francis Blankenberg, MD; Frandics Chan, MD, PhD; and Terry E. Robinson,

More information

Radiologic characterization of emphysema's pattern of distribution - a subjective approach

Radiologic characterization of emphysema's pattern of distribution - a subjective approach Radiologic characterization of emphysema's pattern of distribution - a subjective approach Poster No.: C-0866 Congress: ECR 2014 Type: Educational Exhibit Authors: J. Praia, C. Maciel, J. Pereira, J. Albuquerque,

More information

The relationship between lung function impairment and quantitative computed tomography in chronic obstructive pulmonary disease

The relationship between lung function impairment and quantitative computed tomography in chronic obstructive pulmonary disease Eur Radiol (2012) 22:120 128 DOI 10.1007/s00330-011-2237-9 COMPUTED TOMOGRAPHY The relationship between lung function impairment and quantitative computed tomography in chronic obstructive pulmonary disease

More information

Difference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction

Difference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction ISPUB.COM The Internet Journal of Pulmonary Medicine Volume 4 Number 2 Difference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction

More information

PULMONARY FUNCTION TESTING. Purposes of Pulmonary Tests. General Categories of Lung Diseases. Types of PF Tests

PULMONARY FUNCTION TESTING. Purposes of Pulmonary Tests. General Categories of Lung Diseases. Types of PF Tests PULMONARY FUNCTION TESTING Wyka Chapter 13 Various AARC Clinical Practice Guidelines Purposes of Pulmonary Tests Is lung disease present? If so, is it reversible? If so, what type of lung disease is present?

More information

RESPIRATORY PHYSIOLOGY Pre-Lab Guide

RESPIRATORY PHYSIOLOGY Pre-Lab Guide RESPIRATORY PHYSIOLOGY Pre-Lab Guide NOTE: A very useful Study Guide! This Pre-lab guide takes you through the important concepts that where discussed in the lab videos. There will be some conceptual questions

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Hunninghake GM, Hatabu H, Okajima Y, et al. MUC5B promoter

More information

Interpreting pulmonary function tests: Recognize the pattern, and the diagnosis will follow

Interpreting pulmonary function tests: Recognize the pattern, and the diagnosis will follow REVIEW FEYROUZ AL-ASHKAR, MD Department of General Internal Medicine, The Cleveland Clinic REENA MEHRA, MD Department of Pulmonary and Critical Care Medicine, University Hospitals, Cleveland PETER J. MAZZONE,

More information

Basic approach to PFT interpretation. Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic

Basic approach to PFT interpretation. Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic Basic approach to PFT interpretation Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic Disclosures Received honorarium from Astra Zeneca for education presentations Tasked Asked

More information

Maximal expiratory flow rates (MEFR) measured. Maximal Inspiratory Flow Rates in Patients With COPD*

Maximal expiratory flow rates (MEFR) measured. Maximal Inspiratory Flow Rates in Patients With COPD* Maximal Inspiratory Flow Rates in Patients With COPD* Dan Stănescu, MD, PhD; Claude Veriter, MA; and Karel P. Van de Woestijne, MD, PhD Objectives: To assess the relevance of maximal inspiratory flow rates

More information

E. Senéterre*, F. Paganin**, J.M. Bruel*, F.B. Michel**, J. Bousquet**

E. Senéterre*, F. Paganin**, J.M. Bruel*, F.B. Michel**, J. Bousquet** Eur Respir J, 1994, 7, 596 6 DOI: 1.1183/931936.94.73596 Printed in UK - all rights reserved Copyright ERS Journals Ltd European Respiratory Journal ISSN 93-1936 TECHNICAL NOTE Measurement of the internal

More information

Detection and Severity Scoring of Chronic Obstructive Pulmonary Disease Using Volumetric Analysis of Lung CT Images ABSTRACT

Detection and Severity Scoring of Chronic Obstructive Pulmonary Disease Using Volumetric Analysis of Lung CT Images ABSTRACT chest imaging Iran J Radiol. 2012;9(1):22-27. DOI: 10.5812/iranjradiol.6759 Iranian Journal of RADIOLOGY RADIOLOGYwww.iranjradiol.com Detection and Severity Scoring of Chronic Obstructive Pulmonary Disease

More information

Functional Respiratory Imaging

Functional Respiratory Imaging Functional Respiratory Imaging (FRI) to assess the bioequivalence of inhaled medication Jan De Backer, MSc, PhD, MBA CEO BABE 2014 Functional Respiratory Imaging (FRI) FRI outcome parameters Added value

More information

4.6 Small airways disease

4.6 Small airways disease 4.6 Small airways disease Author: Jean-Marc Fellrath 1. INTRODUCTION Small airways are defined as any non alveolated and noncartilaginous airway that has an internal diameter of 2 mm. Several observations

More information

Research Protocol: Project summary

Research Protocol: Project summary Research Protocol: First clinical study with AiDA on patients as presented in the manuscript Can a single-breath nanoaerosol inhalation detect emphysema? A case-control study Project summary Nanoparticles

More information

Pulmonary emphysema is a chronic obstructive pulmonary disease and worldwide the sixth and 12th most common cause of mortality and morbidity, respecti

Pulmonary emphysema is a chronic obstructive pulmonary disease and worldwide the sixth and 12th most common cause of mortality and morbidity, respecti ORIGINAL RESEARCH THORACIC IMAGING Afarine Madani, MD Viviane De Maertelaer, PhD Jacqueline Zanen, PhD Pierre Alain Gevenois, MD, PhD Pulmonary Emphysema: Radiation Dose and Section Thickness at Multidetector

More information

Pulmonary Function Testing

Pulmonary Function Testing In the Clinic Pulmonary Function Testing Hawa Edriss MD, Gilbert Berdine MD The term PFT encompasses three different measures of lung function: spirometry, lung volumes, and diffusion capacity. In this

More information

Visual Assessment of CT Findings in Smokers With Nonobstructed Spirometric Abnormalities in The COPDGene Study

Visual Assessment of CT Findings in Smokers With Nonobstructed Spirometric Abnormalities in The COPDGene Study 88 Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation Original Research. Visual Assessment of CT Findings in Smokers With Nonobstructed Spirometric Abnormalities in The COPDGene Study

More information

Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects

Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects Use of GOLD and ATS Criteria Connie Paladenech, RRT, RCP, FAARC Benefits and Limitations of Pulmonary Function Testing Benefits

More information

CT Densitometry as a Predictor of Pulmonary Function in Lung Cancer Patients

CT Densitometry as a Predictor of Pulmonary Function in Lung Cancer Patients Send Orders of Reprints at bspsaif@emirates.net.ae The Open Respiratory Medicine Journal, 2012, 6, 139-144 139 CT Densitometry as a Predictor of Pulmonary Function in Lung Cancer Patients Fiachra Moloney

More information

of the right B 10 fourth, r = 0.476, p < ; B 10

of the right B 10 fourth, r = 0.476, p < ; B 10 Yamashiro et al. CT of Chronic Obstructive Pulmonary Disease Cardiopulmonary Imaging Original Research Tsuneo Yamashiro 1,2 Shin Matsuoka 3 Raúl San José Estépar 4 Mark T. Dransfield 5 Alejandro Diaz 6,7

More information

Understanding the mode of action of a drug using Functional Respiratory Imaging (FRI) Roflumilast Study. Jan De Backer, MSc, PhD, MBA CEO

Understanding the mode of action of a drug using Functional Respiratory Imaging (FRI) Roflumilast Study. Jan De Backer, MSc, PhD, MBA CEO Understanding the mode of action of a drug using Functional Respiratory Imaging (FRI) Roflumilast Study Jan De Backer, MSc, PhD, MBA CEO IPAC RS/UF Orlando Inhalation Conference March 20, 2014 OVERVIEW

More information

Ventilatory Mechanics in Patients with Cardio-Pulmonary Diseases. Part III. On Pulmonary Fibrosis

Ventilatory Mechanics in Patients with Cardio-Pulmonary Diseases. Part III. On Pulmonary Fibrosis Ventilatory Mechanics in Patients with Cardio-Pulmonary Diseases Part III. On Pulmonary Fibrosis Kazuaki SERA, M.D. Pulmonary function studies have been undertaken on the pulmonary fibrosis as diagnosed

More information

Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene

Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene Emily S. Wan, John E. Hokanson, James R. Murphy, Elizabeth A. Regan, Barry J. Make, David A. Lynch, James D. Crapo, Edwin K.

More information

PULMONARY FUNCTION. VOLUMES AND CAPACITIES

PULMONARY FUNCTION. VOLUMES AND CAPACITIES PULMONARY FUNCTION. VOLUMES AND CAPACITIES The volume of air a person inhales (inspires) and exhales (expires) can be measured with a spirometer (spiro = breath, meter = to measure). A bell spirometer

More information

6- Lung Volumes and Pulmonary Function Tests

6- Lung Volumes and Pulmonary Function Tests 6- Lung Volumes and Pulmonary Function Tests s (PFTs) are noninvasive diagnostic tests that provide measurable feedback about the function of the lungs. By assessing lung volumes, capacities, rates of

More information

Imaging Emphysema 3-Helium MR Imaging

Imaging Emphysema 3-Helium MR Imaging Imaging Emphysema 3-Helium MR Imaging Edwin J.R. van Beek MD PhD MEd FRCR Professor of Radiology and Medicine Carver College of Medicine, University of Iowa, USA. Permanent Visiting Professor of Radiology,

More information

Cardiopulmonary Imaging Original Research

Cardiopulmonary Imaging Original Research Cardiopulmonary Imaging Original Research Yamashiro et al. CT of Chronic Obstructive Pulmonary Disease Downloaded from www.ajronline.org by 37.44.197.226 on 12/3/17 from IP address 37.44.197.226. Copyright

More information

Air trapping window: an appropriate narrow window setting of inspiratory high-resolution CT in the diagnosis of small airway disease

Air trapping window: an appropriate narrow window setting of inspiratory high-resolution CT in the diagnosis of small airway disease Air trapping window: an appropriate narrow window setting of inspiratory high-resolution CT in the diagnosis of small airway disease Poster No.: C-0651 Congress: ECR 2014 Type: Scientific Exhibit Authors:

More information

Quantitative assessment of cross-sectional area of. small pulmonary vessels in patients with COPD. using inspiratory and expiratory MDCT

Quantitative assessment of cross-sectional area of. small pulmonary vessels in patients with COPD. using inspiratory and expiratory MDCT Quantitative assessment of cross-sectional area of small pulmonary vessels in patients with COPD using inspiratory and expiratory MDCT ( 慢性閉塞性肺疾患における吸気呼気 CT を用いた 肺末梢血管面積の定量的評価 ) 千葉大学大学院医学薬学府環境健康科学専攻 (

More information

Outline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?

Outline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado

More information

Kerstin Cederlund, MD, PhD; Ulf Tylén, MD, PhD; Lennart Jorfeldt, MD, PhD; and Peter Aspelin, MD, PhD

Kerstin Cederlund, MD, PhD; Ulf Tylén, MD, PhD; Lennart Jorfeldt, MD, PhD; and Peter Aspelin, MD, PhD Classification of Emphysema in Candidates for Lung Volume Reduction Surgery* A New Objective and Surgically Oriented Model for Describing CT Severity and Heterogeneity Kerstin Cederlund, MD, PhD; Ulf Tylén,

More information

The effects of emphysema on airway disease: Correlations between multi-detector CT and

The effects of emphysema on airway disease: Correlations between multi-detector CT and The effects of emphysema on airway disease: Correlations between multi-detector CT and pulmonary function tests in smokers (COPD における胸部 CT で評価した気腫性病変が吸気呼気の気道形態に与える影響 ) 千葉大学大学院医学薬学府環境健康科学専攻呼吸器内科学 ( 主任 :

More information

Respiratory System Mechanics

Respiratory System Mechanics M56_MARI0000_00_SE_EX07.qxd 8/22/11 3:02 PM Page 389 7 E X E R C I S E Respiratory System Mechanics Advance Preparation/Comments 1. Demonstrate the mechanics of the lungs during respiration if a bell jar

More information

Overview of Obstructive Diseases of the Lung, Lung Physiology and Imaging Modalities

Overview of Obstructive Diseases of the Lung, Lung Physiology and Imaging Modalities Overview of Obstructive Diseases of the Lung, Lung Physiology and Imaging Modalities Jann Mortensen Final Phil meeting, 29 april 2004 Obstructive disease Definition Epidemiologi Mechanisms Natural history

More information

#8 - Respiratory System

#8 - Respiratory System Page1 #8 - Objectives: Study the parts of the respiratory system Observe slides of the lung and trachea Equipment: Remember to bring photographic atlas. Figure 1. Structures of the respiratory system.

More information

APSR RESPIRATORY UPDATES

APSR RESPIRATORY UPDATES APSR RESPIRATORY UPDATES Volume 4, Issue 7 Newsletter Date: July 2012 APSR EDUCATION PUBLICATION Inside this issue: Quantitative imaging of airways Small-Airway Obstruction and Emphysema in Chronic Obstructive

More information

Small Airways Disease. Respiratory Function In Small Airways And Asthma. Pathophysiologic Changes in the Small Airways of Asthma Patients

Small Airways Disease. Respiratory Function In Small Airways And Asthma. Pathophysiologic Changes in the Small Airways of Asthma Patients Small Airways Disease Respiratory Function In Small Airways And Relevant Questions On Small Airway Involvement In How can small airway disease be defined? What is the link between small airway abnormalities

More information

Respiratory System. Chapter 9

Respiratory System. Chapter 9 Respiratory System Chapter 9 Air Intake Air in the atmosphere is mostly Nitrogen (78%) Only ~21% oxygen Carbon dioxide is less than 0.04% Air Intake Oxygen is required for Aerobic Cellular Respiration

More information

Functional Impairment in Emphysema: Contribution of Airway Abnormalities and Distribution of Parenchymal Disease

Functional Impairment in Emphysema: Contribution of Airway Abnormalities and Distribution of Parenchymal Disease Functional Impairment in Emphysema Chest Imaging Original Research Zelena A. Aziz 1 Athol U. Wells 2 Sujal R. Desai 3 Stephen M. Ellis 4 Amanda E. Walker 5 Sharyn MacDonald 6 David M. Hansell 1 Aziz ZA,

More information

Differential diagnosis

Differential diagnosis Differential diagnosis The onset of COPD is insidious. Pathological changes may begin years before symptoms appear. The major differential diagnosis is asthma, and in some cases, a clear distinction between

More information

A Primer on Reading Pulmonary Function Tests. Joshua Benditt, M.D.

A Primer on Reading Pulmonary Function Tests. Joshua Benditt, M.D. A Primer on Reading Pulmonary Function Tests Joshua Benditt, M.D. What Are Pulmonary Function Tests Used For? Pulmonary function testing provides a method for objectively assessing the function of the

More information

Normal variance in emphysema index measurements in 64 multidetector-row computed tomography

Normal variance in emphysema index measurements in 64 multidetector-row computed tomography JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 4, 2013 Normal variance in emphysema index measurements in 64 multidetector-row computed tomography Bruno Hochhegger, 1 Klaus L. Irion, 2

More information

Is there any correlation between the ATS, BTS, ERS and GOLD COPD s severity scales and the frequency of hospital admissions?

Is there any correlation between the ATS, BTS, ERS and GOLD COPD s severity scales and the frequency of hospital admissions? Respiratory Medicine (2004) 98, 178 183 Is there any correlation between the ATS, BTS, ERS and GOLD COPD s severity scales and the frequency of hospital admissions? Maria Tsoumakidou, Nikolaos Tzanakis,

More information

Anyone who smokes and/or has shortness of breath and sputum production could have COPD

Anyone who smokes and/or has shortness of breath and sputum production could have COPD COPD DIAGNOSIS AND MANAGEMENT CHECKLIST Anyone who smokes and/or has shortness of breath and sputum production could have COPD Confirm Diagnosis Presence and history of symptoms: Shortness of breath Cough

More information

High resolution computed tomography (HRCT) assessment of β 2 -agonist induced bronchodilation in chronic obstructive pulmonary disease patients

High resolution computed tomography (HRCT) assessment of β 2 -agonist induced bronchodilation in chronic obstructive pulmonary disease patients European Review for Medical and Pharmacological Sciences High resolution computed tomography (HRCT) assessment of β 2 -agonist induced bronchodilation in chronic obstructive pulmonary disease patients

More information

To assess the pulmonary impairment in treated pulmonary tuberculosis patients using spirometry

To assess the pulmonary impairment in treated pulmonary tuberculosis patients using spirometry Original Research Article To assess the pulmonary impairment in treated pulmonary tuberculosis patients using spirometry Dhipu Mathew 1, Kirthana G 2, Krishnapriya R 1, Srinivasan R 3 1 Assistant Professor,

More information

Quantitative assessment of emphysema distribution in smokers and patients with a 1 -antitrypsin deficiency

Quantitative assessment of emphysema distribution in smokers and patients with a 1 -antitrypsin deficiency Respiratory Medicine (2006) 100, 94 100 Quantitative assessment of emphysema distribution in smokers and patients with a 1 -antitrypsin deficiency Trine Stavngaard, Saher B. Shaker, Asger Dirksen Department

More information

Vascular Enhancement and Image Quality of CT Venography: Comparison of Standard and Low Kilovoltage Settings

Vascular Enhancement and Image Quality of CT Venography: Comparison of Standard and Low Kilovoltage Settings Cardiopulmonary Imaging Original Research Fujikawa et al. Vascular Enhancement and Image Quality of CTV Cardiopulmonary Imaging Original Research Atsuko Fujikawa 1 Shin Matsuoka Kenji Kuramochi Tatsuo

More information

Preoperative risk assessment with computed tomography in patients undergoing lung cancer surgery

Preoperative risk assessment with computed tomography in patients undergoing lung cancer surgery Original Article Preoperative risk assessment with computed tomography in patients undergoing lung cancer surgery Kazuhiro Ueda, Junichi Murakami, Toshiki Tanaka, Masataro Hayashi, Kazunori Okabe, Kimikazu

More information

Analisi avanzata dello washout di gas inerti

Analisi avanzata dello washout di gas inerti Analisi avanzata dello washout di gas inerti (relation to models & imaging) Sylvia Verbanck Volume (L) Flow (L/s) R, X (kpa.l -.s) volume (L) volume (L) Non-invasive lung function testing spirometry impedance

More information

Gender Differences in the Severity of CT Emphysema in COPD*

Gender Differences in the Severity of CT Emphysema in COPD* Original Research COPD Gender Differences in the Severity of CT Emphysema in COPD* Mark T. Dransfield, MD; George R. Washko, MD; Marilyn G. Foreman, MD, FCCP; Raul San Jose Estepar, PhD; John Reilly, MD,

More information

Lung mechanics in subjects showing increased residual volume without bronchial obstruction

Lung mechanics in subjects showing increased residual volume without bronchial obstruction Lung mechanics in subjects showing increased residual volume without bronchial obstruction S VULTERINI, M R BIANCO, L PELLICCIOTTI, AND A M SIDOTI From the Divisione di Medicina Generale, Ospedale Fatebenefratelli,

More information

Quantitative CT Measurement of Cross-sectional Area of Small Pulmonary Vessel in COPD:

Quantitative CT Measurement of Cross-sectional Area of Small Pulmonary Vessel in COPD: Quantitative CT Measurement of Cross-sectional Area of Small Pulmonary Vessel in COPD: Correlations with Emphysema and Airflow Limitation Shin Matsuoka, MD, PhD, George R. Washko, MD, Mark T. Dransfield,

More information

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Understanding the contribution of native tracheobronchial structure to lung function: CT assessment of airway morphology in never smokers

Understanding the contribution of native tracheobronchial structure to lung function: CT assessment of airway morphology in never smokers Diaz et al. Respiratory Research (2015) 16:23 DOI 10.1186/s12931-015-0181-y RESEARCH Open Access Understanding the contribution of native tracheobronchial structure to lung function: CT assessment of airway

More information

PULMONARY FUNCTION TESTS

PULMONARY FUNCTION TESTS Chapter 4 PULMONARY FUNCTION TESTS M.G.Rajanandh, Department of Pharmacy Practice, SRM College of Pharmacy, SRM University. OBJECTIVES Review basic pulmonary anatomy and physiology. Understand the reasons

More information

Pathological and radiological approach to the small airway disease in asthma: Limitation of current inhaled corticosteroid therapy

Pathological and radiological approach to the small airway disease in asthma: Limitation of current inhaled corticosteroid therapy Allergology International (2004) 53: 1 6 Review Article Pathological and radiological approach to the small airway disease in asthma: Limitation of current inhaled corticosteroid therapy Hiroshi Tanaka,

More information

Fractal analysis of low attenuation clusters on computed tomography in chronic obstructive pulmonary disease

Fractal analysis of low attenuation clusters on computed tomography in chronic obstructive pulmonary disease Tanabe et al. BMC Pulmonary Medicine (2018) 18:144 https://doi.org/10.1186/s12890-018-0714-5 RESEARCH ARTICLE Open Access Fractal analysis of low attenuation clusters on computed tomography in chronic

More information

COMPREHENSIVE RESPIROMETRY

COMPREHENSIVE RESPIROMETRY INTRODUCTION Respiratory System Structure Complex pathway for respiration 1. Specialized tissues for: a. Conduction b. Gas exchange 2. Position in respiratory pathway determines cell type Two parts Upper

More information

Stability of the EasyOne ultrasonic spirometer for use in general practice

Stability of the EasyOne ultrasonic spirometer for use in general practice Blackwell Publishing AsiaMelbourne, AustraliaRESRespirology1323-77992006 Blackwell Publishing Asia Pty Ltd2006113306310MiscellaneousCalibration of an ultrasonic spirometerjae Walters et al. Respirology

More information

Chapter 3. Pulmonary Function Study Assessments. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.

Chapter 3. Pulmonary Function Study Assessments. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 3 Pulmonary Function Study Assessments 1 Introduction Pulmonary function studies are used to: Evaluate pulmonary causes of dyspnea Differentiate between obstructive and restrictive pulmonary disorders

More information

Outcomes in the NLST. Health system infrastructure needs to implement screening

Outcomes in the NLST. Health system infrastructure needs to implement screening Outcomes in the NLST Health system infrastructure needs to implement screening Denise R. Aberle, MD Professor of Radiology and Bioengineering David Geffen School of Medicine at UCLA 1 Disclosures I have

More information

What s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university

What s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university What s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university Management stable COPD Relieve symptoms Improve exercise tolerance Improve health status Prevent

More information

Pediatric chest HRCT using the idose 4 Hybrid Iterative Reconstruction Algorithm: Which idose level to choose?

Pediatric chest HRCT using the idose 4 Hybrid Iterative Reconstruction Algorithm: Which idose level to choose? Journal of Physics: Conference Series PAPER OPEN ACCESS Pediatric chest HRCT using the idose 4 Hybrid Iterative Reconstruction Algorithm: Which idose level to choose? To cite this article: M Smarda et

More information

The role of Pulmonary function Testing In Interstitial lung disease in infants. [ ipft in child ]

The role of Pulmonary function Testing In Interstitial lung disease in infants. [ ipft in child ] The role of Pulmonary function Testing In Interstitial lung disease in infants [ ipft in child ] Introduction Managing infants with diffuse lung disease (DLD) suspected to have interstitial lung disease

More information

COPD: early detection, screening and case-finding: what is the evidence? Prof. Jan-Willem Lammers, Md PhD Department of Respiratory Diseases

COPD: early detection, screening and case-finding: what is the evidence? Prof. Jan-Willem Lammers, Md PhD Department of Respiratory Diseases COPD: early detection, screening and case-finding: what is the evidence? Prof. Jan-Willem Lammers, Md PhD Department of Respiratory Diseases «If you test one smoker with cough every day You will diagnose

More information

Chapter 6. Hester Gietema Cornelia Schaefer-Prokop Willem Mali Gerard Groenewegen Mathias Prokop. Accepted for publication in Radiology

Chapter 6. Hester Gietema Cornelia Schaefer-Prokop Willem Mali Gerard Groenewegen Mathias Prokop. Accepted for publication in Radiology Chapter 6 Interscan variability of semiautomated volume measurements in intraparenchymal pulmonary nodules using multidetector-row computed tomography: Influence of inspirational level, nodule size and

More information

DIAGNOSTIC NOTE TEMPLATE

DIAGNOSTIC NOTE TEMPLATE DIAGNOSTIC NOTE TEMPLATE SOAP NOTE TEMPLATE WHEN CONSIDERING A DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS (IPF) CHIEF COMPLAINT HISTORY OF PRESENT ILLNESS Consider IPF as possible diagnosis if any of the

More information

DOES SMOKING MARIJUANA INCREASE THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE?

DOES SMOKING MARIJUANA INCREASE THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE? DOES SMOKING MARIJUANA INCREASE THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE Pubdate: Tue, 14 Apr 2009 Source: Canadian Medical Association Journal (Canada) Copyright: 2009 Canadian Medical Association

More information

Pediatric High-Resolution Chest CT

Pediatric High-Resolution Chest CT Pediatric High-Resolution Chest CT Alan S. Brody, MD Professor of Radiology and Pediatrics Chief, Thoracic Imaging Cincinnati Children s s Hospital Cincinnati, Ohio, USA Pediatric High-Resolution CT Short

More information

Cardiac CT - Coronary Calcium Basics Workshop II (Basic)

Cardiac CT - Coronary Calcium Basics Workshop II (Basic) Cardiac CT - Coronary Calcium Basics Workshop II (Basic) J. Jeffrey Carr, MD, MSCE Dept. of Radiology & Public Health Sciences Wake Forest University School of Medicine Winston-Salem, NC USA No significant

More information

Doses from pediatric CT examinations in Norway Are pediatric scan protocols developed and in daily use?

Doses from pediatric CT examinations in Norway Are pediatric scan protocols developed and in daily use? Doses from pediatric CT examinations in Norway Are pediatric scan protocols developed and in daily use? Eva Godske Friberg * Norwegian Radiation Protection Authority, P.O. Box, Østerås, Norway Abstract.

More information